
somnovia is designed to offer therapeutic techniques and exercises based on evidence-based psychological-psychotherapeutic treatment methods, suitable for patients with insomnic disorder, to support them in managing their insomnic disorder. It is for independent use by patients aged 18+. It is not intended to replace healthcare provider treatments or provide information for diagnostic or therapeutic decisions. Indications: Nonorganic insomnia (F51.0), Sleep-onset and sleep-maintenance disorders (G47.0).
Pricing
Paid
Manufacturer price €236.00 per prescription (90 days). DiGA directory: https://diga.bfarm.de/en/verzeichnis/02097
Category
Digital Therapeutics
Tags
—
Added
Sep 2026
Conditions (ICD-10)
Categories
Pros
- Permanently listed in the German BfArM DiGA directory
- Prescribable and reimbursed by German statutory health insurance
- Therapeutic area: Nervous System, Psychological